Kolexia
Schaepelynck-Belicar Pauline Endocrinologie
Schaepelynck-Belicar Pauline
Endocrinologie
Hôpital Sainte Marguerite
Marseille, France
90 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Diabète de type 1 Diabète Hypoglycémie Diabète de type 2 Insulinorésistance Hyperglycémie Maladies métaboliques {{person.topmesh9.name}} {{person.topmesh10.name}}

Collaborateurs

Voir plus
Benhamou Pierre-Yves
Benhamou Pierre-Yves
Hôpital Nord Grenoble, La Tronche, France
Hanaire Helene
Hanaire Helene
Hôpital Rangueil, Toulouse, France
Penfornis Alfred
Penfornis Alfred
Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France
Renard Eric
Renard Eric
Hôpital Lapeyronie, Montpellier, France

Industries

Voir plus
B3TSI
26 collaboration(s)
Dernière en 2023
Lilly
24 collaboration(s)
Dernière en 2023
Pharma Dom
15 collaboration(s)
Dernière en 2022
PASCALEO
14 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes.
Diabetes, obesity & metabolism   22 janvier 2024
Impact of chronic emotions and psychosocial stress on glycemic control in patients with type 1 diabetes. Heterogeneity of glycemic responses, biological mechanisms, and personalized medical treatment.
Diabetes & metabolism   17 octobre 2023
SP12: Observational Study of the Use of DBLG1 System in Real Life
Essai Clinique (Diabeloop)   06 septembre 2023
BETTER: Interventional Before/After Study of the Effect of the DBLG1 System With TERUMO MEDISAFE WITH Insulin Pump on Glucose Control of Patients With Type 1 Diabetes in France. The BETTER Trial
Essai Clinique (Diabeloop)   13 juin 2023
Quelles modalités pour une mise sous pompe à insuline en ambulatoire dans les centres initiateurs français ? Étude O’APIday
Médecine des Maladies Métaboliques   01 mai 2023
An Unsafe/Safe Typology in People with Type 2 Diabetes: Bridging Patients' Expectations, Personality Traits, Medication Adherence, and Clinical Outcomes.
Patient preference and adherence   25 mai 2022
Reply to Letter by Alexander Seibold on "Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices" by Yannis Préau, et al. (doi: 10.1089/dia.2020.0674).
Diabetes technology & therapeutics   28 mars 2022
The switch from rapid-acting to concentrated regular insulin improves glucose control in type 2 diabetes patients on pump therapy: A cohort survey.
Diabetes & metabolism   30 octobre 2021
Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study .
Sensors (Basel, Switzerland)   13 septembre 2021
No more hypoglycaemia on days with physical activity and unrestricted diet when using a closed-loop system for 12 weeks: A post hoc secondary analysis of the multicentre, randomized controlled Diabeloop WP7 trial.
Diabetes, obesity & metabolism   03 juin 2021